Janssen-Cilag GmbH

Janssen-Cilag GmbH Firmenkenndaten im Überblick

Product Range

Immunology, Oncology, Haematology, Neurology/Psychiatry, Rheumatology, Pain
Infectious Diseases: Virology, Mycology, Parasitology

Key Research Areas Janssen-Cilag GmbH

AIDS, Alzheimer’s disease, respiratory diseases (non-infectious, e.g. asthma, COPD) bacterial infections (therapy), skin diseases except skin cancer, rheumatological diseases, vaccines for prophylaxis, cancer: antineoplastic therapy to treat solid tumors, cancer: antineoplastic therapy to treat hematologic tumors, gastrointestinal and liver diseases (non-infectious and non-cancerous infectious), tropical diseases of the poor, mental diseases, viral infections, pain

R&D Expenditure

(All data based on corporate information from member Janssen-Cilag GmbH , as of: 11/2015)
Unless indicated otherwise, data and keywords refer to the company's human therapeutics sector in Germany and to that of its international Group worldwide.
The Pharmaceutical Industry in Germany

Germany: The Perfect Location for Research, Production and Sales - a publication by GERMANY TRADE & INVEST and vfa
Brochure Download